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Recent technological developments in recording health care delivery have led to major 
research opportunities for epidemiologists and others. There has been a dramatic 
increase in the availability of “routine data” for research purposes, including data from 
electronic medical records, administrative data for billing purposes, disease registries, 
and sources of sociodemographic data. Examples of routine data include data from 
medical records in the UK in the Clinical Practice Research Database, administra-
tive data from Surveillance, Epidemiology and End Results Medicare, and registry 
data from the Danish National Registry of Patients. The key aspect that differentiates 
routine data from other research data sources is the reasons for which the data were 
collected, since routine data are not specifically collected for research purposes. These 
data are increasingly available from various health care settings and geographic loca-
tions. They present innovative, efficient, and cost-effective prospects with which to 
answer key research questions. However, use of these data for research leads to specific 
challenges for researchers and for policymakers and clinicians in using studies based 
on such data.
At present, the strengths, limitations, and biases of available routine data sources are 
unclear. This confusion has been compounded by incomplete or inadequate reporting of 
this type of research. An example is the reporting of studies undertaken to validate the 
quality of data derived from electronic health records. Two recent systematic reviews 
demonstrated poor reporting of validation studies of data from routine data sources, 
thereby hampering their utility.1,2
In the last few years, increasing emphasis has been placed on improving the quality 
of reporting research with a view to increasing the usefulness of research findings.3–5 
In 2008, an international collaboration produced the Strengthening the Reporting 
of Observational Studies in Epidemiology (STROBE) statement to improve the 
reporting of three types of observational research, ie, cross-sectional, case-control, 
and cohort studies.6 STROBE has been endorsed by more than 100 health journals. 
Most research using routinely collected health data is observational in design, so 
STROBE guidelines should apply to these studies. However, due to the general nature 
of STROBE, specific issues related to reporting research using routinely collected 
data are not addressed.
REporting of studies Conducted using Observational Routinely collected Data 
(RECORD) was established to explore and address specific reporting issues related to 
research using routine data. The issues were explored amongst stakeholders during 
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a workshop convened at the Infectious Disease Research 
Network Primary Care Database Symposium (January 27, 
2012, in London, UK). Over 100 people participated in the 
workshop, including five conveners of the STROBE initia-
tive. Strong interest was expressed in the idea of developing 
a reporting guideline specific to research using routinely 
collected health data. There was general agreement that 
specific areas related to the reporting of research based on 
routinely collected health data warranted an extension of the 
STROBE statement. Some of the specific issues discussed 
at the Infectious Disease Research Network meeting, which 
are likely to be major themes when using routinely collected 
data, included description of database characteristics, valida-
tion of diagnostic codes and algorithms to identify exposures 
and outcomes, and record linkage methodology. These 
issues are not specifically covered in the STROBE check-
lists. Therefore, we are proceeding with a formal guideline 
development process, in close collaboration with members 
of the STROBE group, to ensure consistent methods and 
to make this a valuable addition to the STROBE statement. 
The RECORD initiative was created as an international 
collaborative process. The RECORD initiative aims to 
develop an extension of the STROBE checklist to enhance 
specifically transparent reporting of studies based on routine 
data sources.
The steering committee of the RECORD initiative has 
been selected to ensure a broad representation of people with 
expertise and experience in the use of different data types 
and sources, and representing diverse geographical locations 
and with experience in rigorous development of reporting 
guidelines. In addition, a working group with a wide range of 
expertise will be appointed to inform the development of the 
guidelines. A broadly representative group of stakeholders will 
be used to contribute to a modified Delphi consensus which 
will be a key component of the RECORD guideline develop-
ment. If readers of this editorial feel they could usefully con-
tribute at a stakeholder level, please visit the website (http://
www.record-statement.org). Your input is most welcome.
Following the brainstorming session at the Primary 
Care Database Symposium in January 2012, a search of the 
Enhancing the QUAlity and Transparency Of health Research 
(EQUATOR) Network reporting guidelines library was carried 
out. The EQUATOR Network (http://www.equator-network.
org) is an international initiative committed to improving and 
upholding transparent and accurate reporting of scientific 
publications; the network hosts a comprehensive database of 
reporting guidelines.7 Three checklists were identified that 
aim to aid in the conduct and critical appraisal of studies 
using routinely collected data for comparative effectiveness 
research.8–10 However, these guidelines focus primarily on 
research methods rather than specifically reporting of such 
research, they are focused on comparative effectiveness 
research and therefore do not apply to most observational 
research; additionally they have not been widely accepted 
by journal editors and were not developed with international 
stakeholder consensus or as part of a formal extension of 
STROBE. Formal reporting guidelines for studies using 
routinely collected health data, with multidisciplinary expert 
stakeholder involvement and collaboration from STROBE 
authors, will help ensure the transparency of the methods 
used in this growing field of research.
Development of the RECORD guidelines will follow the 
process proposed by the EQUATOR network as previously used 
in developing the STROBE and other reporting guidelines.11–14 
Members of the EQUATOR executive are also members of 
the steering and working committees for RECORD. The 
EQUATOR Network recommends five phases to develop 
a reporting guideline optimally, including initial steps, pre-
meeting activities, a face-to-face consensus meeting, post-
meeting activities, and post-publication activities. The initial 
steps include providing evidence about the quality of routinely 
collected data reports and undertaking a Delphi exercise. 
Both of these activities should be completed and presented 
during a face-to-face meeting of the working group and other 
invited stakeholders. To facilitate uptake, dissemination, and 
other implementation strategies, the creation of a website 
is recommended (http://www.record-statement.org). The 
website can also act as an important portal for communication 
by interested parties and will enable invitation of criticisms 
and recommendations to improve the guideline.
Dissemination, endorsement, and implementation of 
the RECORD guidelines will be critical for them to have 
impact. As such energy will be invested into maximizing 
the publication strategy and encouraging endorsement and 
adherence to the guidelines. This will start from an early 
stage of guideline development by working closely with 
journal editors from the outset of the initiative. Attendance 
and presentations at relevant meetings of methodologists 
and journal editors will be key to the success of the process. 
We will work closely with editors to ensure endorsement and 
implementation of the guidelines and encourage individu-
als submitting research derived using routine data sources 
to use the RECORD guidelines. We anticipate evaluating 
whether the use of RECORD improves the completeness of 
reporting of routinely collected data research. We encourage 
others to do likewise.
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RECORD will set the standard for improving the 
quality of reporting of research using routine data sources. 
Furthermore, the tool could help researchers to review the 
available literature and improve areas of methodological 
concern, thereby improving the quality of research produced 
from routinely collected health data. Most importantly, the 
adequate reporting of research will allow consumers of 
such research (including journal editors, peer reviewers, 
scientists, clinicians, and policy makers) to understand the 
work, enabling them to deduce its internal and external 
validity. The introduction of the RECORD guidelines is 
likely to enhance the knowledge and skills of those using 
the data and those undertaking the research in academia or 
industry. Transparent reporting is critical to increase public 
engagement with science.
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